Nashville, TN – There are several things already that appear to differential Medical Marijuana Inc (OTCMKTS:MJNA) from other cannabis stocks out there. One of such things is that the company always aims to put existing and potential customers straight on what they need to know about marijuana-based products. Such is important in promoting sales, and it has worked for the company. Something else that is gaining popularity in the company is its efforts to tap anti-aging market.
As it is already known, the company operates through subsidiaries that offer anything from pure cannabidoil oil and cannabis-based products. Additionally, the company offers to educates on a wide range of marijuana products and their usage.
Cannabis for anti-aging
While marijuana is already known to help in conditions such as cancer, especially with regards to pain relief, marijuana is also cited a potent remedy for aging. It can be used as a natural anti-aging product that does not expose users to adverse side effects. At recent conference focusing on cannabis for anti-aging, Medical Marijuana Inc (OTCMKTS:MJNA) sought to drive some points home about of pot as an anti-aging remedy.
The global conference on anti-aging is known as A4M. It markets to over 26,000 doctors and scientists drawn from 120 countries worldwide. Many issues came up for discussion at this year’s edition of A4M in Las Vegas mid this month. One of the issues that emerged from the conference included the market potential of anti-aging products and how natural remedies are becoming popular.
For example, the global value of the anti-aging industry is expected to hit $292 billion by 2015. While the current world population above 60 years is only 10%, the aging population is expected to hit 22% by 20150. Spending on natural anti-aging remedies is also expected to be more than $243 billion by next year. Such figures and estimate indicate that Medical Marijuana Inc (OTCMKTS:MJNA) is hitting the right chord with its cannabis-based anti-aging campaigns.
Beyond the aging issues, legal marijuana is expected be worth about $35 billion by 2020. That means a huge revenue opportunity for the company whose main focus is on cannabis products.
Like most cannabis stocks, cash appears to be an issue for Medical Marijuana Inc (OTCMKTS:MJNA). The company had just about $1.57 million in cash at the end of the most recent quarter. That was a decline from the previous quarter.